Primary Immunodeficiency Diseases Market worth US$7.5 bn by 2023, Newborn Screening in Emerging Markets to be Key Opportunity
Primary immunodeficiency disease (PIDD) comprises group of rare disorders, mostly genetic in nature, wherein a...
February 19 2016